Cargando…

REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States

Some trials have found that patients from the United States derive less benefit than patients enrolled outside the United States. This prespecified REDUCE-IT (Reduction of Cardiovascular Events with Icosapent Ethyl - Intervention Trial) subgroup analysis was conducted to determine the degree of bene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhatt, Deepak L., Miller, Michael, Brinton, Eliot A., Jacobson, Terry A., Steg, Ph. Gabriel, Ketchum, Steven B., Doyle, Ralph T., Juliano, Rebecca A., Jiao, Lixia, Granowitz, Craig, Tardif, Jean-Claude, Olshansky, Brian, Chung, Mina K., Gibson, C. Michael, Giugliano, Robert P., Budoff, Matthew J., Ballantyne, Christie M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004453/ https://www.ncbi.nlm.nih.gov/pubmed/31707829 http://dx.doi.org/10.1161/CIRCULATIONAHA.119.044440

Ejemplares similares

REDUCE-IT INTERIM: accumulation of data across prespecified interim analyses to final results
por: Olshansky, Brian, et al.
Publicado: (2020)

Reduction in Revascularization With Icosapent Ethyl: Insights From REDUCE-IT Revascularization Analyses
por: Peterson, Benjamin E., et al.
Publicado: (2020)

Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE‐IT PCI
por: Peterson, Benjamin E., et al.
Publicado: (2022)

Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL
por: Majithia, Arjun, et al.
Publicado: (2021)

Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE‐IT
por: Olshansky, Brian, et al.
Publicado: (2023)

Potential effects of icosapent ethyl on cardiovascular outcomes in cigarette smokers: REDUCE-IT smoking
por: Miller, Michael, et al.
Publicado: (2022)

Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE‐IT
por: Selvaraj, Senthil, et al.
Publicado: (2022)

Effectiveness of icosapent ethyl on first and total cardiovascular events in patients with metabolic syndrome, but without diabetes: REDUCE-IT MetSyn
por: Miller, Michael, et al.
Publicado: (2023)

Rationale and design of REDUCE‐IT: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial
por: Bhatt, Deepak L., et al.
Publicado: (2017)

Lipid Effects of Icosapent Ethyl in Women with Diabetes Mellitus and Persistent High Triglycerides on Statin Treatment: ANCHOR Trial Subanalysis
por: Brinton, Eliot A., et al.
Publicado: (2018)

Mineral oil: safety and use as placebo in REDUCE-IT and other clinical studies
por: Olshansky, Brian, et al.
Publicado: (2020)

Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study
por: Ballantyne, Christie M., et al.
Publicado: (2019)

miR‐3146 induces neutrophil extracellular traps to aggravate gout flare
por: Shan, Lizhen, et al.
Publicado: (2021)

Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment
por: Weintraub, William S., et al.
Publicado: (2022)

3146 Effect of a Junior Faculty Mentoring Program on Confidence in Targeted Academic Skills
por: Kitsis, Elizabeth, et al.
Publicado: (2019)

High-sensitivity troponin-T levels and associated health conditions in 3146 women aged 46
por: Ollila, Meri-Maija, et al.
Publicado: (2023)

Complete genome sequence of Paenibacillus konkukensis sp. nov. SK3146 as a potential probiotic strain
por: Jung, Hae-In, et al.
Publicado: (2021)

Consistent LDL‐C response with evolocumab among patient subgroups in PROFICIO: A pooled analysis of 3146 patients from phase 3 studies
por: Stroes, Erik, et al.
Publicado: (2018)

Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200–500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study
por: Brinton, Eliot A, et al.
Publicado: (2013)

Effect of bempedoic acid plus ezetimibe fixed-dose combination vs ezetimibe or placebo on low-density lipoprotein cholesterol in patients with type 2 diabetes and hypercholesterolemia not treated with statins
por: Bays, Harold E., et al.
Publicado: (2021)

Potential Probiotic Acceptability of a Novel Strain of Paenibacillus konkukensis SK 3146 and Its Dietary Effects on Growth Performance, Intestinal Microbiota, and Meat Quality in Broilers
por: Moon, Seung-Gyu, et al.
Publicado: (2022)

The reduction in cardiovascular risk in REDUCE-IT is due to eicosapentaenoic acid in icosapent ethyl
por: Steg, Ph Gabriel, et al.
Publicado: (2021)

Prescription omega-3 fatty acid products containing highly purified eicosapentaenoic acid (EPA)
por: Brinton, Eliot A., et al.
Publicado: (2017)

Heart Rate and Use of Beta-Blockers in Stable Outpatients with Coronary Artery Disease
por: Steg, Ph. Gabriel, et al.
Publicado: (2012)

Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry
por: Fauchier, Laurent, et al.
Publicado: (2015)

Maintaining Cardiovascular Health in Patients With Mixed Dyslipidemia Optimizing the Management of Hypertriglyceridemia and Non-HDL Cholesterol
por: Ito, Matthew, et al.
Publicado: (2009)

Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry
por: Steg, Ph Gabriel, et al.
Publicado: (2012)

The Travel and Tropical Medicine Manual, 4th Edition
por: Granowitz, Eric V.
Publicado: (2009)

Trepid and Intrepid Travelers
por: Granowitz, Eric V.
Publicado: (2005)

An In-Silico Model of Lipoprotein Metabolism and Kinetics for the Evaluation of Targets and Biomarkers in the Reverse Cholesterol Transport Pathway
por: Lu, James, et al.
Publicado: (2014)

Characterization of Culex pipiens Complex (Diptera: Culicidae) Populations in Colorado, USA Using Microsatellites
por: Kothera, Linda, et al.
Publicado: (2012)

Elevated Triglycerides (≥150 mg/dL) and High Triglycerides (200–499 mg/dL) Are Significant Predictors of New Heart Failure Diagnosis: A Real-World Analysis of High-Risk Statin-Treated Patients
por: Toth, Peter P, et al.
Publicado: (2019)

Hypertriglyceridemia is associated with an increased risk of peripheral arterial revascularization in high‐risk statin‐treated patients: A large administrative retrospective analysis
por: Toth, Peter P., et al.
Publicado: (2019)

The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus
por: Pitt, Bertram, et al.
Publicado: (2021)

A limited market: the recruitment of gay men as surrogacy clients by the infertility industry in the USA
por: Jacobson, Heather
Publicado: (2018)

The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint clinical perspective from the National Lipid Association and the American Society for Preventive Cardiology
por: Virani, Salim S., et al.
Publicado: (2023)

Cross-border reproductive care in the USA: Who comes, why do they come, what do they purchase?
por: Jacobson, Heather
Publicado: (2020)

Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis
por: Toth, Peter P., et al.
Publicado: (2019)

Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate Lyase
por: Bilen, Ozlem, et al.
Publicado: (2016)

Improving Outcomes After Myocardial Infarction in the US Population
por: Kayani, Waleed T., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jh2l5thli3a8acg6c58400c2qt